Much to the relief of CVS Health investors, good things still happen to cheap stocks. The pharmacy and health-care giant’s shares rallied on Wednesday after the company reported strong first-quarter results, its first full quarter since closing on its acquisition of health insurer Aetna. Revenue of $61.6 billion, adjusted earnings of $1.62 a share and same store sales growth of 3.8% all topped analyst expectations. CVS also boosted its full-year profit forecast.

Source: Wall Street Journal May 01, 2019 15:13 UTC